Welcome to the RadNet Newsroom

LOS ANGELES, Dec. 06, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Sidoti & Company December 2022 Small-Cap Virtual Conference on Wednesday, December 7, 2022 at 3:15 p.m. Eastern Time.

LOS ANGELES, Nov. 28, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported that its lung artificial intelligence subsidiary, Aidence, and Google Health, a division of Alphabet, Inc. (NASDAQ: GOOG), announce an agreement to license Google Health’s AI research model for lung nodule malignancy prediction on CT imaging. Aidence will develop, validate and bring this model to the market to support the early and accurate diagnosis of lung cancer and the reduction of unnecessary procedures in screening programs.

LOS ANGELES, Nov. 25, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the BofA Securities 2022 Leveraged Finance Conference in Boca Raton, FL on Tuesday, November 29, 2022 at 11:50 a.m. Pacific Time (2:50 p.m. Eastern Time)  

LOS ANGELES, Nov. 09, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 349 owned and operated outpatient imaging centers, today reported financial results for its third quarter of 2022.

The 2022 Annual Meeting of the Radiological Society of North America (RSNA) is almost here, and RadNet is ready. With an increasing and significant focus on Artificial Intelligence, RadNet will showcase its AI division and all the ways our team is providing better patient care, detecting cancers earlier, and improving the overall accuracy of medical imaging. RadNet continues to be a leader in imaging, and RSNA attendees can discover real innovations at Booth #1329.

LOS ANGELES, Nov. 01, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today reported it has acquired a 75% interest in London-based Heart & Lung Imaging Limited (“Heart&Lung Health” or “HLH”).

LOS ANGELES, Oct. 28, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its third quarter 2022 financial results on Wednesday, November 9^th, 2022 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

LOS ANGELES, Oct. 11, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today reported its joint venture, New Jersey Imaging Network (NJIN), has acquired the outpatient radiology assets of Montclair Radiology, the owner of six imaging centers in northern New Jersey.

LOS ANGELES, Aug. 09, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 353 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2022.